Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis
AUTOR(ES)
Miyoshi, N
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2778541Documentos Relacionados
- β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
- TRIB3 Functional Q84R Polymorphism Is a Risk Factor for Metabolic Syndrome and Carotid Atherosclerosis
- UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer
- ABC of colorectal cancer: Innovative treatment for colon cancer
- Screening for colorectal cancer: a general-practice-based study.